Improving Prognostic Accuracy in Locally Advanced Rectal Cancer: Integrating Tumor Deposits with Lymph Node Metastases—A Retrospective Study
Gastroenterology Insights · 07.04.2026 · 17 (2) · 24
DOI: 10.3390/gastroent17020024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastroenterology Insights, online erschienen am 07.04.2026. Verfasst von Yisong Hong und 9 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, the Natural Science Foundation of Guangdong Province, the Fundamental Research Funds for the Central Universities, Sun Yat-sen University.
Abstract (Originalsprache)
Objectives
This study aimed to investigate the impact of TDs on the survival of patients with locally advanced rectal cancer (LARC). Additionally, we propose a novel staging method that combines TDs and lymph node metastases (LNMs) to enhance prognostic accuracy.
Methods
Patients with LARC were retrospectively identified from the Surveillance, Epidemiology, and End Results (SEER) database and a Sun Yat-sen University (SYSU) cohort. Propensity score matching (PSM) was utilized to minimize selection bias when evaluating TDs. We quantitatively stratified TDs counts and integrated them with regional LNMs to formulate a novel tumor node metastasis (TNM) staging system. Furthermore, a prognostic nomogram incorporating TDs was constructed and validated to predict survival.
Results
Overall, 19,991 patients were included in the SEER database, with 2667 (13.3%) TDs-positive and 17,324 (86.7%) TDs-negative tumors. After PSM, multivariate Cox analysis reveals that TDs are an independent adverse prognostic factor (HR = 1.521, 95% CI: 1.366–1.693, p < 0.001). Patients with high-risk group (TDs > 4) at any TNM stage exhibit OS comparable to or worse than that of stage IIIC disease. For patients staged as T4N2M0, the high-risk group (TDs > 4) demonstrates OS equivalent to stage IV disease. The nomogram achieved C-indices of 0.713 (training cohort, n = 8586) and 0.789 (external validation cohort, n = 304), with AUCs of 0.774 (3-year) and 0.710 (5-year).
Conclusions
The presence of TDs is associated with poorer OS, and integrating TDs with LNMs improves the accuracy of TNM staging. The nomogram (C-index = 0.789) provides enhanced prognostic stratification and survival prediction.
Förderung
- the National Natural Science Foundation of China
- the Natural Science Foundation of Guangdong Province
- the Fundamental Research Funds for the Central Universities, Sun Yat-sen University
- the Sixth Affiliated Hospital of Sun Yat-sen University Clinical Research—‘1010’ Program
- the Medical Scientific Research Foundation of Guangdong Province
- the Science and Technology Program of Guangzhou
- the Talent Project of the Sixth Affiliated Hospital of Sun Yat-sen University
- the Excellent Talent Training Project of the Sixth Affiliated Hospital of Sun Yat-sen University
Zitieren
APA
Hong, Y., Wang, P., Wu, Y., Chen, X., Yuan, C., He, R., Lin, J., Jiang, Z., Wu, J., & Huang, M. (2026). Improving Prognostic Accuracy in Locally Advanced Rectal Cancer: Integrating Tumor Deposits with Lymph Node Metastases—A Retrospective Study. Gastroenterology Insights, 17(2), 24. https://doi.org/10.3390/gastroent17020024
Vancouver
Hong Y, Wang P, Wu Y, Chen X, Yuan C, He R, et al. Improving Prognostic Accuracy in Locally Advanced Rectal Cancer: Integrating Tumor Deposits with Lymph Node Metastases—A Retrospective Study. Gastroenterology Insights. 2026;17(2):24. doi:10.3390/gastroent17020024
BibTeX
@article{Hong2026,
author = {Hong, Yisong and Wang, Puning and Wu, Yuanhui and Chen, Xiaoqiong and Yuan, Chuanwei and He, Rongzhao and Lin, Jinxin and Jiang, Zhipeng and Wu, Jingjing and Huang, Meijin},
title = {Improving Prognostic Accuracy in Locally Advanced Rectal Cancer: Integrating Tumor Deposits with Lymph Node Metastases—A Retrospective Study},
journal = {Gastroenterology Insights},
year = {2026},
volume = {17},
number = {2},
pages = {24},
doi = {10.3390/gastroent17020024}
}
EUVIMED